The United Kingdom has announced that it has approved a new coronavirus vaccine developed by US pharmaceutical giant Pfizer and others for the Omicron strain.
On the 3rd, the British regulatory authorities announced that the Omicron strain "BA.1" developed by Pfizer and Germany's Biontech and the "bivalent vaccine" that corresponds to two types of conventional new coronaviruses, 12 years old and above. announced that it was approved as a booster vaccination.
The UK also approved a bivalent vaccine against the Omicron strain developed by Moderna last month.
The UK's Medicines and Medical Products Regulatory Agency, which manages the safety of vaccines, commented, ``I'm glad that the second vaccine has been approved for the autumn booster.''
Regarding the vaccine corresponding to the Omicron strain, the US CDC = Center for Disease Control officially recommended on the 1st that the bivalent vaccine corresponding to the Omicron strain "BA.4" and "BA.5" be used as a booster. In addition to the announcement, an application for approval of a bivalent vaccine corresponding to "BA.1" has been submitted in Japan, and preparations are underway in each country for additional vaccinations after autumn.